New patent for Global Blood drug OXBRYTA May 4, 2024 AutoBot News 0 Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten… Source